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ABSTRACT
Effects of Physical and Emotional Stress,
Catecholamines and Naloxone on HDL and LDL
Cholesterol Levels in Rats and Man
by
Andrew G. Goliszek, Doctor of Philosophy
Utah State
Major Professor:
Department:

Uni~ersity,

1983

Dr • .LeGrande C • .Ellis

Biology

A series of investigations were undertaken to determine
whether physical or emotiona l stress, catecholamines or
naloxone (B-endorphon blocker) would increase serum total
cholesterol and LDL and HDL levels.

Physical stress given

daily over a period of time caused a steady increase in serum
total cholesterol and LDL without a significantly altering
high density lipoproteins (HDL) or serum triglycerides.
Daily injections of epinerphrine in oil caused an increase in
both serum total cholesterol and LDL levels while daily
injections of norepinephrine did not.

Reversal of the

treatments caused a reversed response in both groups of rats.
Similar increases in both total cholesterol and LDL levels
occurred in graduate students during preparation for their
comprehensive written or oral thesis /dissertation defense.

X

Injection of eigher dichloroisoproterenol (M.W.

=

248)

or naloxone (M.W. = 346) in rats prior to stress inhibited
the increase in total cholesterol and LDL levels, although
naloxone at the dosage given was more effective, possibly
due to its larger molecular weight.

When naloxone plus

epinephrine was injected into non-stressed rats, there was
a significant increase in total cholesterol and LDL levels,
but the increase was not as great as that of groups injected
with epinephrine only.

Stressed, adrenalectomized rats

exhibited higher cholesterol and LDL levels than the normal
reported range for rats of their age and weight, but their
levels did not differ from those of stressed, sham-operated
rats indicating that the adrenals

~

se are not needed for

stress-induced elevation of blood LDL levels.

(84 pages)

INTRODUCTION
Beginning in the early twentieth century, cholesterol
was suspected as being a contributor to atherosclerosis and
coronary heart disease (Sabine, 1977).

Thus, an excess of

plasma cholesterol is thought to contribute to deposition of
plaques that eventually leads to coronary ischemia and
finally to myocardial infarction.

These initial studies

focused exclusively on serum total cholesterol.

It was not

until the last few decades that researchers recognized the
importance of lipoproteins as the carriers of cholesterol
throughout the circulatory system (Barret al., 1951; Levy,
1981).
The bulk of studies done on the accumulation of
cholesterol deposits in blood vessels has been done with
respect to diet, exercise, and lifestyle.

Several studies

have been undertaken over the years to ascertain if stress
increases plasma cholesterol levels.

Most of the latter

studies, however, have concentrated on the measurement of
total cholesterol levels and not on the individual lipoprotein fractions which are now considered to be the
critical factors in potentiating atherosclerosis.

Further-

more, almost all studies to date have been on human subjects.
This type of research has limitations since manipulations on
human subjects is subject to scrutiny and data that could
otherwise be collected are not.

By utilizing laboratory

2

animals, a more lucid picture can be drawn concerning stressrelated lipoprotein levels and the results can be applied to
a better understanding of atherosclerosis in human patients.
The last decade has brought us closer to unravelling
the pathogenic mechanism of coronary artery disease and
today, more than ever, increasing our knowledge is vital in
order to curb the threat of a disease which generally
manifests itself only after years or even decades.

With all

the cholesterol studies done over the years, no thorough or
systematic research attempted has been undertaken to
evaluate the effects on specific lipoprotein levels.

There-

fore, the purpose of this study was to ascertain how cholesterol and lipoprotein fractions are altered during
stressful situations by utilizing laboratory animals as well
as human subjects.

Understanding the results of this type

of study may give us a better insight into how stress in
today's society plays a major role in the increasing rate of
heart disease.

3

REVIEW OF LITERATURE
Lipoprotein - Cholesterol Pathway
Cholesterol is a necessary component of all eucaryotic
plasma membranes and is also the precursor of steroid
hormones such as progesterone, estradiol, testosterone, and
cortisol (Figs. 1 and 2).

Too much cholesterol can be

lethal, however, and the main concern of many studies has
been on the elucidation of the pathway by which cholesterol
is transported.
Cholesterol does not exist in free solution (Gofman
et al., 1966; Levy, 1981) but enters and leaves the plasma
bound to specific proteins.

The four major classes of

plasma lipoproteins are Chylomicra, Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL), and High
Density Lipoproteins (HDL).

Cells outside the liver and

intestine obtain cholesterol from the plasma rather than
synthesizing it de

~

(Stryer, 1981).

Depending on

whether the lipoprotein is either high density or low
density, cholesterol is either transported away from the
peripheral tissues to the liver or is transported toward the
peripheral tissues from the liver.

The steps in cholesterol

uptake by peripheral tissues is as follows (Fig. 3):
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1.

LDL binds to specific receptors on the cell surface
of non-hepatic cells and is then internalized by
endocytosis.

2.

The protein component of the LDL is hydrolyzed to
free amino acids by lysosomes and the cholesterol
esters in the LDL are hydrolyzed by lysosomal
cholesterol esterase.

3.

The unesterified cholesterol is either used for
membrane and steroid biosynthesis or is reesterified
for storage within the cell.

Rate of cholesterol formation in the liver is dependent
on the formation of 3-hydroxy-3-methyl glutaryl CoA
reductase, which is the first stage in cholesterol synthesis,
and by LDL receptor feedback regulation (Brown and Goldstein,
1976).

When cholesterol is abundant within the cell, new

receptors are not synthesized and, therefore, there is no
consequent cellular uptake of cholesterol (Brown, 1983;
Eisenberg and Levy, 1976; Montgomeryet al., 1980).

When plasma

concentrations of LDL are high, cholesterol is deposited in
the peripheral tissues inducing atherosclerosis.
Cholesterol, Lipoproteins and
Coronary Heart Disease
Studies of cardiovascular disease in human populations
have for many years emphasized the importance of serum total
cholesterol as a critical factor in coronary heart disease
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(Davis et al., 1937; Lerman and White, 1946; Steiner and
Domanski, 1943).

During the last few decades, however,

researchers have focused on the partition of cholesterol
into various lipoprotein fractions (Goldstein and Brown,
1977; Levy, 1981; Morrisett et al., 1975).

Furthermore, the

lipoprotein fractions have been examined as to their role in
atherosclerosis (Barr, 1953; Barret al., 1951; Gofman
et al., 1956, 1966; Gordon et al., 1977; Noma et al., 1979;
Oliver andBoyd, 1955) as well as to how they themselves are
affected by variables such as exercise (Clarkson et al.,
1981; Hartung et al., 1980), diet (Brown, 1983; Connor et al.,
1961; Flaim et al., 1981; Oliver, 1981), and lifestyle
(Keys, 1955; Stamler, 1978).

According to these and

numerous other studies, the following generalizations can be
made regarding the relationship between cholesterol, lipoproteins, and cardiovascular disease:
l.

An increase in cholesterol concentrations, specifically the LDL-cholesterol, causes an increase in
the risk of cardiovascular disease.

2.

Risk of cardiovascular disease is inversely related
to HDL-cholesterol concentrations.

3.

Physical activity may cause an increase in the HDL
fraction or a decrease in the LDL fraction and thus
reduce the risk of heart disease.

The value of lipoprotein profiles as predictors of CHD
has recently been questioned (Keys, 1955) because of the
short follow-up period in the studies conducted and the lack

9

of attention paid to mortality.

Despite this controversy,

researchers have clearly demonstrated th a t there is a
correlation between low HDL le vels and the pathogenesis of
coronary heart disease (Berge et al., 1982; Brook et al.,
1982; Castelli et al., 1977; Gordon et al., 1977; Kannel
et al., 1979; Levy and Rifkind, 1980; Noma et al., 1979;
Tisi etal., 1981) .

Currently, investigations are being

undertaken to explain the means by which HDL exerts its
apparent protective effect and what are the genetic and
environmental elements that modulate plasma HDL levels (Levy
and Rifkind, 1980).

Particular attention is being given to

LDL and its r ole as the principle factor in potentiating
atherosclerosis (Castelli et al., 1977 ; Levy, 1981).
Stress as a Factor in
After:Lng-c11ollestel:OI-Levels
Mann and White (1953) were among the first researchers
to study the effects of stress on cholesterol l evels.

They

proposed that the physiological response to stress is a
decrease in the total serum cholesterol, but they based
their conclusions on a series of experiments in which the
stress was feed deprivation.

Other researchers have since

refuted th eir conclusions and have shown that cholesterol
can increase significantly during stressful conditions.

For

example, when hospitalized patients were maintained on
balanced diets, and exercise was carefully regulated, serum
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cholesterol increased significantly with occurrence of
emotionally stressful situations (Wolf et al., 1962).
Furthermore, it has been shown that serum total cholesterol
can increase during stressful situations by as much as 35%
despite constant diet and exercise (McCabe et al., 1959).
Moreover, significant deviations in total cholesterol levels
may occur within hours in certain individuals during shortterm stress (Peterson et al., 1960, 1962).

Thomas and

Eisenberg (1957) and Wertlake and Wilcox (1959) observed
striking variations in day to day serum cholesterol with
serum cholesterol increasing significantly one day and
becoming stable the next.

Changes in serum cholesterol have

also been observed in men undergoing job loss (Kasl et al.,
1968) and in professionals such as accountants during
periods of occupational stress (Friedman et al., 1958).

A

long-term study by Uhley and Friedman (1959) has shown that
rats exposed to intermittent stress over a

10-month period

had a 47% greater plasma cholesterol concentration than
controls and concluded that stress may accelerate
atherosclerosis.
Beginning in the late SO's, a series of observations
were made on changes in serum cholesterol levels of students
during stressful periods.
et al.

Thomas and Murphy (1958),

Wertlake

(1958), Grundy and Griffin (1959), and Wertlake and

Wilcox (1959) all found statistically significant
increases in serum cholesterol under mental and emotional
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stress of examinations.
et al.

Sloane et a l.

(1961) and Sloane

(1962) described the "hi gh cholesterol type student"

in which there were elevations in cholesterol levels in
students described as excessively ambitious, hostile, and
restlessly tense.
Other types of stressful situations have been observed
in which the stress of physical activity or the anticipation
of a demanding situation affected cholesterol levels .
Cholesterol levels increased with physical acti v ity
(Naughton and McCoy , 196 6) and wi th high energy output , more
drive, and more concern with meeting dead lines (Sletten
et al., 1964).

Rahe and Arthur (1967) further showed that

cholesterol levels increased during periods of stress even
though the physical activity of the subjects was at a
maximum befo re and during the time of increased cholesterol
levels.

Later studies demonstrated that increased choles-

terol was correlated with having failed and with a feeling
of being overburdened (Ra he et al ., 1968) or with feelin gs
of anger, fear, and lethargy (Rahe et al., 1971).

In

occupational studies, elevated serum cholesterol was
correlated with self-criticism and dependability (Jenkins
et al., 1968), cyclic job stress (Friedman et al, 1958), and
extreme drive and competitivenes s (Friedman and Rosenman,
1959, 1960).

Kasl et aL (1968) reported that anticipation

of job loss did not increase cholesterol leve ls, but it did
increase serum uric acid leve l s .

Groen et al. (1952)
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observed fluctuation s of ch o l es terol lev els in response to
stress independent of the t ype of diet and suggested that
the fluctuations resulte d from infection, exertion or
emotional tension.
Most of the studies me ntioned thus far have been concerned with measurement of serum total cholesterol without
regard to the lipoprotein fractions carrying the cholesterol.
A paucity of information, therefore, exists in this area of
inv estigation.

Dreyfus and Czaczkes (1959) found that HDL

was higher than LDL du r ing s tressful examination periods.
Jenkins et al.

(1966) and Francis (1979), on the other hand,

found that it was the LDL-cholesterol that increased significantly during stressful periods while Harlan et al.
(1967) found VLDL to be associated with unrestrained
aggressiveness.

In reviewing the studies associated with

plasma lipid variability in response to emotional arousal,
Dimsdale and Herd (1982) concluded that, with rare
e x ceptions, stressful e v ents can significantly increase
cholesterol b y as much a s 65 % even though dietary intake or
physical activity are rigidly controled.

These studies

illustrate the need to examine non-dietary lipid metabolism
and to elucidate the relationship between lipoprotein
fractions and stress.
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Stress Hormones and
Cholesterol Levels
It has been well established that a response to stress
involves the releas e of several "stress hormones" including
ad renal cortica l stero ids and the catecholamines epinephrine
and norepinephrine.

Epinephrine produces a hyperglycemic

effect which augments energy reserves and enables an
organism to cope with stress very quick ly (Hole, 1981).

It

has produ ced myocardial necroses when administered e x trinsically or when the animal underwent experimental stimulation
or le s ions of the brainstem (Raab et al., 1964).
et al.

Friedman

(1960) showed that stress discharged catecholamines

into the circulatory system during emotional stress.

Thus,

epinephrine release is necessary for short-term survival,
but can be harmful when relied upon for long-term survival
during physical or emotional stress.
Cortisol in man and corticos terone in rodents mobilizes
amino acids from muscle t issue and fa tty acids from adipose
tis s u e

(Guyton, 1981) .

Thi s mechanism makes amino acids

availab l e for new protein synthesis or gluconeogenesis and
fa t s availab le for energy during starvation or stress .
Since cholesterol is a precursor molecule for s teroid
hormones (Turner and Bagnara , 1976), an increase in serum
cholesterol during stress may be a mechanism whereby synthesis of stress hormones is maximized.

The rise in

cholesterol levels during stress could be intensified as a
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result of CNS stimulation or as a result of feedback caused
by a decreased level of steroid hormones.

Gunn et al.

(1960) concluded that a CNS me chanism exists which under
certain conditions is capable of significantly influencing
arterial atherogenesis.

When rabbits were fed a diet high

in cholesterol along with chronic hypothalmic stimulation,
the animals exhibited a greater degree of aortic and
coronary atherosclerosis t han did the non-stimulated
controls fed the same diet .

Similar l y, stimulation of the

hypothalamus and thalamus evoked a serum turbidity response
thought to be associated with an increase in the total lipid
concentration (Correll, 1969) in which chronic hyperchol esterolemia resulted from bilateral hypothalamic injury
involving the ventral medial nuclei, the fornices, and the
medial portion of the lateral hypothalamus (Friedman and
Byers, 1972).
Current investigations have centered around B-endorphinergic systems and their involvement in stress reactions.
In particular, B-endorphin has been found to contain opiatelike properties.

They also serve as tranquilizing agents

and analgesic regulators and are called upon as a reserve
mechanism in emergency situations (Emrich and Millan, 1982).
In humans, electrical stimulation of the periaqueductal gray
and other centers of the brainstem induces a release of Bendorphin (Hosobuchi et al., 1977).

Furthermore, endorphin

15
blockers such as naloxone have been shown to decrease the
pain threshold of acupuncture (Mayer et al., 1977), thus
demonstrating the analgesic effect of endorphin.
More recent investigations have shown that B-endorphin
increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats (Van Loon and Appel, 1980; Van
Loon et al., 1981) and that psychosomatic idsorders may be
related to a dysfunction of endorphinergic reactions during
stress (Emrich and Millan, 1982).

Since catecholamines are

important in stress responses and endorphins play a role in
catecholamine release, both endorphins and catecholamines
may represent an integral part of the overall stress mechanism.

Other variables, such as diet and heredity, may act

synergistically along with stress to compound its effects
and cause an increase in cholesterol levels.
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MATERIALS AND METHODS
Animals
Male Wistar rats weighing 300-400 grams at the start
of the experiments were maintained in an animal care
facility at Utah State University on a 14:10 hr (L:D) cycle
and were given feed (Wayne Lab-Blox) ad libitum except when
noted otherwise.

All rats were housed in groups and adapted

to handling by being handled daily for 3 weeks prior to the
start of the experimental period.
Rats were divided into groups of 6 according to the
amount and type of stress that was administered or groups of
8 according to the type of catecholamine or receptor blocker
that was injected.

Stress was always administered in the

form of electrical tail shock (150 Volts; 2 shocks per
second) for a period of 30 seconds (Appendix A).

The groups

were divided as follows:
A.

Shocked randomly once a day.

B.

Shocked randomly 8 times per day.

C.

Same as B except that shock was preceded by a
buzzer.

When rats learned to associate the buzzer

with shock, the buzzer was set off at different
times of the day and night in addition to the times
of shock.
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D.

Injected Sub Q daily with epinephrine (1 mg/kg
body wt. in corn oil).

E.

Injected Sub Q daily with norepinephrine (1 mg/kg
body wt. in corn oil).

F.

Injected with dichloroisoproterenol (1 mg/kg body
wt. in saline) and stressed 30 minutes following
injection.

G.

Injected with naloxone (1 mg/kg body wt. in saline)
and stressed 30 minutes following injection.

H.

Injected with naloxone plus epinephrine.

I.

Adrenalectomized and stressed.

Blood samples from groups A through E were collected
weekly while blood samples from Groups F through I were
collected 2 hours following stress or following injection.
All samples were collected approximately the same time
between 9:00 and 10:00 a.m.

Rats in group I were

adrenalectomized and then allowed 10 days to recover from
surgery before stress was administered.

Corticosterone (5

mgs in oil 3 days prior to stress) was administered in order
to replace that lost by removed adrenals.
Rats were fasted for 10 hours prior to collecting
blood (3 ml) which was done by cardiac puncture after ether
anesthesia.

Serum was separated from the erythrocytes after

refrigeration at

8°c

within 2 hours by centrifugation at

5000 X g in a refrigerated centrifuge for 30 minutes.

All
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samples were ana lyzed colorimetrically within 24 hours for
total cholesterol, HDL, and triglycerides.

Total choles-

terol was determined using a total cholesterol reagent kit
(Fisher Scientific) ; HDL was determined using a magnesiumphosphotungstate reagent kit (Fisher Scientific); serum
triglyceride was determined using the ESC triglyceride nonenzymatic procedure (Stanbio Diagnostics); LDL was calculated using the formula by Friedwald et al.

(1972).

Comparison between experimental and control groups was
determined by Student's t-test and .05 was considered to be
significant.
Human Subjects
Eleven volunteer graduate students were also used to
study the effects of stress on cholesterol and lipoprotein
levels.

Blood was taken from the vein during a period of

non-stress following a 10 hour fast and then again just
prior to comprehensive exams or dissertation defense.
was separated and analyzed as previously stated.

Serum

All the

volunteers were carefully screened so that errors due to
other factors were avoided.

A questionnaire {Appendix B)

was filled out by each student regarding diet, activity, and
lifestyle in order to interpret results more accurately.
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RESULTS
Effect of Physical Stress
on Serum Total Cholestrol
and Lipoprote1n Fract1ons
Serum total cholesterol increased during the first 6
weeks from about 40 to 55 mg/dl and then rose to a maximum
of 80 mg/dl following the introduction of a randomly timed
buzzer as a second form of stress (Fig. 4).

The values for

all groups were significantly increased above control
(p < 0.05) on weeks 3, 4, 7 and 8.

There was no depletion

of red blood cells after spinning of blood during the 8 week
experimental period.
Electrical shock stress over a 6-week period (Fig. 5)
increased LDL levels from about 5 to a maximum of 17 mg/dl.
A sharp rise in value to about 33 mg/dl resulted from introduction of the buzler.

Group C, which was conditioned to

associate the buzzer with electric shock, experienced the
greatest increase in both serum total cholesterol and LDL
levels.
(p

<

Increases in LDL

l~vels

were significantly elevated

0_.05) over controls in group Jl.. from \<Teek 5, in group B

from week 4, and in group C from week 4.

The sharp increase

in both total cholesterol and LDL in groups A and B
following introduction of the buzzer may have been due to
the additional stress caused by the noise or by phermones

0 Control
• Group A (stress lx/day)
..L Group B (stress 8x/day )
.t:. Group C (stress 8x/day
plus buzzer
4x/day)

80

Mg/dl 60

. t
buzzer

40
4

2

6

8

WEEKS

I>.J
0

Fig. · 4. Effects of random Qaily shock on serum total cholesterol.
Shock was administered beginning week 1 (A, p < 0. OS, B,
p<O.OS, and C, p<O.OS compared to control on weeks 3, 4,
7 and 8; ~ :!: sx and C, P< 0. OS compared to A and B on weeks
7 and 8; x + s-).
X

0 Control
e Group A (stress lx/day)
• . Group B (stress 8x/day)

25

h

Group C (stress 8x/day
plus buzzer
4x/day)

Mg/dl 15

5
2

6

4.

8

WEEKS
Fig. 5. Effects of random daily shock on LDL levels. Shock was
administered beginning week 1 (A, p< 0 . OS compared to
contro l from week 5; x + s-, B, p< 0.05 and C, P< 0.05
compared to A and control ~rom week 4;
+ s-, c, p < 0. 05
compared to A and Bon weeks 7 and 8;
+-s-~.

xx

-

X

fV

.....
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released from group C r a ts which associated the buzzer with
electric shock.

HDL leyels fluctuated somewhat during the

first 6 weeks, but then increased following introduction of
the buzzer (Fig. 6).

This slight increase was associated

with the increase in total cholesterol.

Since triglyceride

levels did not change between groups, they were not considered to be a factor that contributed to a rise in
cholesterol levels.

Average cholesterol values for some

laboratory animals are shown in Appendix C.
Effect of Catecholamines on
Serum Total Cholesterol and
Lipoprotein Fractions
Daily subcutaneous injections of epinephrine produced
a significant increase (P < 0.05) in serum total cholesterol
from about 48 to 70 mg/dl (Fig. 7).

Injections of norepi-

nephrine produced a somewhat smaller increase from about 48
to 53 mg/dl which was not signficiant compared with controls
(p < 0.05).

When the treatments were reversed after the

fourth week, the group response was also reversed.
There was a significant increase in LDL levels with
epinephrine injections (P

<

0.05 (Fig. 8), but not with

norepinephrine injections (p > 0.05).

When the two groups

were reversed, the response also reversed.

Despite a rise

on week 2, HDL levels were not significantly affected
(p > 0.05) by either treatment during the entire experimental period (Fig. 9).

Thus, the effects of stress were

0 Control

45

e Group A (stress l x/day)
• Group B (stress Sx/ d a y)
.6.

Group C (stress Sx/day
plus buzz er
4x/day )

Mg/dl 35

25
2

4

6

8

WEEKS
Fig. 6. Effects of random daily shock on HDL levels. Shock was
administered beginning week 1 (A, p < 0. OS compared to
control on weeks 4, 5 and 6 and compared to B and C on
. week 4;
± s;cl.

x

"'
w

80

0

Control

•
•

Epinephrine
Norepinephri11e

*

Mg/dl 60

40
2

4

6

WEEKS

Fig. 7. Effects of· catecholamines on serwn total cholesterol.
Daily injections began on week 1 and treatments were
reversed on week 4 (*, P<O.OS compared to control;

:X±

s:x>·

"'....

o
•

Control
Epinephrine

•

Norepinephrine

*

25

Mg/dl 15

5
2
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6

WEEKS
Fig. B. Effects of catecholamines on LDL levels. Daily injections
began on week land treatments were reversed on week 4 .
(*, P<O.OS compared to control; X:!: sx).
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Fig. 9. Lack of effects of catecholamines on HDL levels. Daily
injections began on week 1 and treatments were reversed
on week 4.
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primarily evidenced by a rise in the serum LDL.

Triglyce-

ride levels did not increase during the experimental period
and were not a factor in cholesterol increase.
Effect of Naloxone and
Dichloroisoproterenol on
Total Cholesterol and
Lipoprotein Levels
Injection with naloxone or dichloroisoproterenol
inhibited the increase of serum total cholesterol (Fig. 10).
Stressed animals, which were not given either blocker,
exhibited significantly higher serum total cholesterol
levels (p < 0.05) than stressed animals which were treated
with one or the other drug prior to stress.

An increase in

LDL levels was also inhibited significantly {p < 0.05) in
treated animals (Fig. 11).

As predicted from previous

experiments, HDL levels did not fluctuate much (Fig. 12),
and therefore, the increase in total cholesterol was associated with the increase in the LDL fraction .

Triglyceride

levels were unaffected by the treatments.
Effect of B-Endorphin Versus
Epinephrine in Altering
Serum Cholesterol and
Lipoprotein Levels
Rats injected with either epinephrine or epinephrine
plus naloxone had significantly higher serum total cholesterol levels (p < 0.05) than control animals (Fig. 13).
animals injected with only epinephrine had significantly

The
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STRESS + NALOXONE
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Fig. 10. Effects of naloxone and d ichloroisoproterenol on total
cholesterol le vels (a, P<O . OS compared to control;
+ s- and a, P<O . OS c ompared to b and c;
+ s-).

x

-

X

x

-

X

"'
ro

25

Mg/dl

D

CONTROL

~

STRESSED

f:::::::J

STRESS + DICHLOROISOPROTERENOL

fMI

STRESS + NALOXONE

15

Fig. 11. Effects of naloxone and dichloroisoproterenol on LDL
levels (a, P<O.OS compared tQ control;
+ s;c and a,
P<O.OS compared to b and c; X:!: SX).
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Fig. 12. Lack of effects of naloxone and dichloroisoproterenol on
HDL levels.

0

CONTROL
EPINEPHRINE

80

EPINEPHRINE + NALOXONE

60
Mg/dl

40

20

w

Fig. 13. Influence of epinephrine on total cholesterol levels
when injected together with naloxone (a, P<O.OS and
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higher total cholesterol levels (p < 0.05) than both the
control group and the group injected with naloxone plus
epinephrine .

LDL levels increased in a similar way (Fig.

14) and were significantly higher in both injected groups
when compared t o their controls (p < 0.05).

LDL was highest

in the epinephrine treated group and was signficiantly
higher (p < 0.05) than the group injected with naloxone plus
epinephrine.

HDL did not vary much between groups (Fig. 15)

and the levels were not significantly different (p < 0.05).
Triglyceride concentrations were not altered during the
treatments.
Effects of Physical Stress
on Serum Total Cholesterol and
Lipoprotein Levels in
Adrenalectomized Rats
After a recovery period of 10 days following surgery,
there was no signif i cant difference (p < 0.05) in cholesterol and lipoprotein levels between adrenalectomized and
sham operated rats 2 hours after stress (Figs. 16, 17, and
18).

Both groups had higher than normal cholesterol and LDL

levels (n ormal range for total cholesterol is 40-50 mg/dl
and for LDL is 3-10 mg/dl, but similar HDL levels to normal
non-stressed rats (normal range for HDL is 25-35 mg/dl ).

D
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Fig. 14. Influence of epinephrine on LDL levels when injected
together with naloxone (a, P < 0. OS and b, P< 0. OS
compared to control;
+ s-).
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Fig. 15. Lack of influence of epinephrine on HDL levels when
injected together with naloxone.
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Fig. 16. Lack of effect of adrenalectomy on total choleste r ol
levels following stress.
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Effects of Emotional Stres s
on Cholesterol and Lipoprotein
Levels in Graduate Students
During Comprehensive Exams
or Dissertation Defense
Graduate students subjected to the stress of comprehensive examinations of dissertation defense had significantly higher (p < 0.05) total cholesterol levels, LDL
levels, and LDL/HDL ratios than they did during periods of
non-stress (Figs. 19, 20, and 21).

HDL levels did not

change significantly (p > 0.05) indicating that most of the
change in total cholesterol was due to the LDL fraction
(Fig. 22).

There was a wide range of variability in both

serum total cholesterol (164-221 mg/dl during non-stress;
183-264 mg/dl during stress) and LDL levels (97-152 mg/dl
during non-stress; 119-174 mg/dl during stress) suggesting
that individual cholesterol and lipoprotein levels during
non-stress may have been influenced by factors such as diet,
heredity, or lifestyle.

However, since every student's

cholesterol and LDL levels increased prior to stress despite
the fact that none of the students reported any changes in
lifestyle, diet or exercise, the increase was assumed to be
the direct result of stress.

Appendix D shows average

cholesterol and lipoprotein values for human populations.
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Fig. 19. Total cholesterol levels in graduate students during
non-stress periods and during emgtional stress
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DISCUSSION
Although much is known about the relationship between
cholesterol and cardiovascular disease, only recently has a
correlation been found between lipoprotein fractions and
atherosclerosis.

The major focus of studies in the past has

been on the effect of diet and exercise on serum total
cholesterol, but there have been a few studies which
emphasized the importance of stress on altering cholesterol
leve ls.

Only a very small part of stress-related choles-

terol research, however, hasdealtwith lipoprotein fractions
(most notably, LDL) as important contributors to stressinduced cardiovascular disease.
As early as 1950, stress was implicated as a main
contributing factor in increasing the risk for coronary
heart disease (Stewart, 1950).

Some of the earlier

investigations showed clearly than the etiology of coronary
heart disease was a consequence of various factors with
stress being one of the more important factors
1967; Russek and Zohman, 1958).

(Russek, 1965,

Additional studies have

also shown that the stress of working long hours is positively correlated with onset of cardiovascular disease
(Breslow and Buell, 1960) as are the effects of social and
cultural factors
1 964) .

(Cassel and Tyroler, 1961; Syme et al.,

·These studies demonstrated that factors other than
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than diet and heredity may be contributing significantly to
the development of heart disease and they focused attention
to the effects of stress in influencing homeostatic
mechanisms.
Rosenman et al.

(1966) found that the significant

prognostic factors in the development of heart disease were
abnormalities in the lipoprotein profiles, hypertension, and
the exhibition of a specific overt behavior pattern called
"Type A"

(excessive drive, aggressiveness, and ambition).

Further evidence by Eastwood and Trevelyan (1971), Groen
et al.

(1972), Bengtsson et al.

(1973), and Wardwell and

Bahnsen (1973) linked coronary heart disease with emotional
stress, depression, and anxiety.

These complex psychological

patterns are often related to social stress and may play a
key role in triggering LDL synthesis which in turn contributed to onset of atherosclerosis.

Moreover, the

strongest evidence for a link to cardiovascular disease
exists for the Type A behavior pattern and incidence of
coronary heart disease (Brand et al., 1976; Harlan, 1980).
Since the Type A individual responds to stress with
greater secretion of catecholamines than the Type B
individual (Friedman et al., 1975; Williams et al., 1982),
the hyperresponsivity to stress in terms of catecholamine
release may represent a mechanism for the expression of
excess coronary events and atherosclerosis among Type A
persons.

Indeed, several past studies have demonstrated

45
the cardiotoxic effects that catecholamines have on heart
tissue (Gazes et al., 1959; Raab, 1943, 1956; Raab et al.,
1962; szakacs et al, 1959) as well as their increased discharge during emotional stress (Elmadjian et al., 1957).
The relationship between emotional stress or trauma and
increased levels of cholesterol and LDL may be more significant in light of the necrotic effect of catecholamines on
heart mucsle and would explain one's increased risk for coronary heartdisease and atherosclerosis under those conditions.
Role of Long-Term Physical
and Emotional Stress in the
Etiology of CHD as a Result
of Increased Cholesterol
and LDL
1'he fact that serum cholesterol in general and LDL in
particular contribute to the onset of atherosclerosis has
been debated by researchers during the past two decades.
Most of the controversy stems from the argument over whether
singlr or multiple factors are responsible for atherosclerotic mechanisms and over which factor plays the leading
role.

If a synergistic effect occurs over a long-term

period, then a single factor could invariably be intensifying the effect of the other factors and hence play a
leading role.
In this study, stress was the single variable that
proved to cause increases in both serum total cholesterol
and LDL levels without significantly altering HDL levels.
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Daily, random stress, both in the form of physical stress
(shock) and emotional stress (anticipation of shock),
produced this effect.

Even though a rise in cholesterol and

LDL was noted within 2 hours following stress in rats, daily
stress over a long-term period (2 months) produced a greater
and continual rise in cholesterol and LDL levels and is,
therefore, a more pathogenic situation than short-term
stress.

Furthermore, the group that was subjected to the

emotional stress was affected the most in terms of overall
increases in total cholesterol and LDL levels.
Human subjects in this study had undergone only
emotional stress of comprehensive exams

or dissertation

defense and therefore physical stress was not involved.
Every student had an increase in total cholesterol and LDL
a few hours prior to the anticipated stressful situation
demonstrating that emotional stress is sufficient to cause
a significant change.

One student, who had taken his exams

prior to the Thanksgiving holiday and who had an elevated
cholesterol level, actually had a decrease in total cholesterol and LDL levels immediately after Thanksgiving despite
the enormous amount of rich foods than he reported eating.
Although this is only one example, it demonstrates that
stress may be a more significant factor in altering the
normal levels of cholesterol and lipoproteins than diet.
There have been several studies which failed to produce
any changes in cholesterol levels when cholesterol was added
(in the form of eggs) to free-living diets already
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containing moderate amounts of cholestero l

(Flynn et al.,

1979; Kummerow and Kim, 1977; Porter et al., 1977; Slater
et al., 1976).

Furthermore, some foods

(such as dairy pro-

ducts) which were once thought to increase cholesterol
levels, have recently been shown to have a hypocholesteremic
effect (Mann, 1977; Mann and Spoerry, 1974;

Richardson, 1978).

This evidence suggests that diet alone may account for only
a small percentage of mortality due to CHD.
If cholesterol and LDL are important in the pathogenesis of coronary he art disease, then th e present study
demonstrates that stress is not only an indirect variable
but an actual catalyst that mediates the stress response.
Because of its ability to increase the levels of serum LDL,
stress may thus be considered one of the principle contributors to the atherosclerotic mechanism.

Other factors such

as diet and heredity may be secondary contributors augmenting
the initial reactions caused by stress.

In this manner, the

risk for CHD would depend on the multiplicative effect of
various factors with one factor, stress, initiating or at
the very lease intensifying the process.
The human liver- produces about 2 grams of cholesterol
per day (Kritchevsky, 1958) while the average American diet
consists of 300-600 mg of cholesterol daily (Connor, 1958;
Connor and Connor, 1983).

As the dietary consumption of

cholesterol increases, the endogenous synthesis of
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cholesterol decrea s es according ly (Bhattathiary a nd
Siperstein, 1963; Frantz et al., 1954; Lang don and Bloch,
1953; Taylor et al., 1960), and unless the daily intake of
cholesterol is very high, normal cholesterol levels are
maintained.

This fact raises the question of why so many

individuals who maintain a proper diet still succumb to
coronary heart disease.

The answer may be that diet is a

factor that is important in the case of some individuals but,
in general, is not significant without the concomitant
effects of various other factors.
Fig. 23 shows a hypothetical scheme in which the
different factors influence the risk of CHD both directly
and indirectly.

Together with diet and heredity, stress

(especially daily stress over a long period of time) no
doubt insures that cholesterol levels will rise above normal
when an organism encounters any stressful situation.

It is

yet unknown why or how stress produces a rise in cholesterol
levels although speculation would suggest that the body is
pr e9aring for trauma by producing the precursor molecule
for steroid hormones.

This ensures short-term survival at

the expense of long-term health and could be the result of
an evolutionary process that developed when long-term
survivability was not an issue.
The rats than were subjected to both physical and
emotional stress exhibited abnormal behavior such as tail
biting and anxiety as well as physiological abnormalities
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such as diarrhea and hi g h chole s terol and LDL levels.

All

these effects were more pronounced in this group (group C)
than the other groups which experienced only physical stress.
Thus, emotional stress may be more important in terms of CHD
pathogenesis than physical stress or it may simply have an
additive effect that compounds an already existing condition.
Further studies are needed in this particular area in order
to delineate between the effects of psychological versus
physical stress on cholesterol and lipoprotein levels.
The Stress Response and its
Link to Atherosclerosis
Through the Action of
Epinephrine and Endorphin
According to Selye's "General Adaptation Syndrome"
(1959), the adaptive mechanisms that are called into operation during exposure to stress are detrimental to certain
physiological processes and may induce a variety of pathologic changes such as hypertension, arthritis, ulcers,
ateriosclerosis, nephrosclerosis, and many others .

Although

not enough direct evidence is available, it is possible that
these diseases may be produced by hormonal excess or
imbalances.
In the present study, rats injected daily with
epinephrine (in oil) exhibited an increase in both total
cholesterol and LDL levels.

When a B-blocker such as

dichloroisoproterenol was injected prior to stress, increase
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in cholesterol and LDL levels was inhibited.

The mechanism

responsible for the increase in cholesterol during stress is
unknown, but the fact that epinephrine is involved in the
general stress response and also stimulates an increase in
serum cholesterol and LDL levels makes possible some theories
involving the cellular uptake of LDL and release of
epinephrine.
It has been well established that new LDL receptors
(called "coated pits") will not be synthesized when the
cellular content of cholesterol is at a maximum (Brown and
Goldstein, 1976).

When this occurs, excess cholesterol is

unable to enter into the cell and is subsequently deposited
in the surrounding tissue in the form of plaques which
eventually harden and cause arteriosclerosis.

Proper

functioning of LDL receptor s is critical because any abnormality will produce hyperlipoprotenemia and hence a very
high risk of coronary heart disea § e.

Epinephrine may inter-

fere with cellular uptake of LDL in several ways
1.

(Fig. 24):

There may be an actual physical interference
whereby epinephrine binds to the cell membrane and
discourages proper functioning of LDL receptors.

2.

There may be indirect interference in that epinephrine activates adenyl cyclase which converts
ATP to cAMP and the cAMP .in turn alters the permeability of the cell membrane.

The cellular change

may be sufficient enough to inhibit the entrance of
at lease some of the LDL mo lecules.
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Fig . 24.

Hypothetical mechanisms by which epinephrine
inhibits cellular uptake o f LDL through receptor
interference.
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3.

Clycogenolysis, stimulated by epinephrine, may
cause an inhibition of LDL receptor function if the
cell is unable to efficiently take up both the
large amount of glucose and the LDL molecules.

These hypothetical schemes are possible if high levels
of epinephrine can interfere with or inhibit receptors.
Since the half life of epinephrine is roughly 30 minutes
(Turner and Bagnara, 1976), short-term stress that causes
release of catecholamines over a short time period may not
have the same effect as long-term stress which causes continued release of catecholamines over a long time period.
In the present study, daily injected epinephrine in oil
represented a longer continual release and was a more
realistic test of long-term catecholamine effect.

The

deleterious e f fect s of epinephrine are no doubt intensified
when the catecholamine is present for a prolonged time
period.

Thus emotional stress, which has been implicated

with coronary heart disease more so than his physical
stress, and which usually manifests itself over a much
longer period of time, is probably the form of stress that
is involved most intimately with the epinephrine-cholesterol

mechanism.
Recent investigations have shown that physical activity
such as daily exercise, increases HDL levels (Huttunen
et al., 1979; Streja and Mymin, 1979) or decreases LDL
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levels (Altekruse and Wilmore, 1973; Lopez et al., 1974).
Since physical activity also increases epinephrine release,
there appears to be an inconsistency with a theory which
correlates a rise in epinephrine with an increase in
cholesterol and LDL levels.

However, this inconsistency may

be explained by a recent finding at the University of Utah
Artificial Organs Division where it was discovered that a
steady exercise regime prior to surgery actually depressed
the rise in epinephrine associated with the trauma of
surgery (Olsen, personal communication).

This adaptation to

continuous physical activity could explain why epinephrine
is not a significant factor in cholesterol and LDL increase
in individuals who exercise regularly.

Furthermore,

epinephrine that is released as a result of stress may not
be subject to inhibition by any adaptive mechanism and
would, therefore, be released even in physically active
individuals whenever they enounter stressful situations.
The present study has also demonstrated that the Bendorphin blocker, naloxone, is able to inhibit a rise in
serum total cholesterol and LDL levels following stress
(electric shock) and that this inhibition is even stronger
than it is in ·the case of rats injected with the Badrenergic blocker dichloroisoproterenol.

Since both

naloxone and dichloroisoproterenol inhibit (albeit not to
the same extent) cholesterol and LDL increases, a mechanism
involving both epinephrine and B-endorphin is likely to be
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operating during stress.

B-endorphins, which are naturally

occuring opiate-like substances

fo~nd

in the brain, are

secreted into the bloodstream during stress and stimulate
catecholamine release thus increasing plasma levels of
epinephrine, norepinephrine . and dopamine (Van Loon and
Appel, 1980).

The rise in epinephrine during a stressful

situation can therefore result from both the regular pathway
via hypothalamic stimulation and from the mechanism which
mediates B-endorphin-induced increases in plasma catecholamines.

This dual pathway would not only enhance an

organism's ability to cope with immediate life threatening
situations but would also enhance an organism's risk of
atherosclerosis by increasing the amount of epinephrine in
the plasma (Fig. 25).
When naloxone was administered prior to stress, there
was virtually a complete inhibition of cholesterol and LDL
synthesis.

Ye t, when naloxone plus epinephrine were admin-

istered, there was a rise in cholesterol and LDL levels
although not as great as when epinephrine alone was
administered.

The inhibition of cholesterol due to naloxone

demonstrates that the B-endorphin pathway is important and
may be a key in understanding how cholesterol and LDL levels
are being altered during stress.

The inhibition of choles-

terol and LDL with naloxone despite stress but the rise in
cholesterol and LDL levels following injection with
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Possible pathways through which stress acts in altering cholesterol
and LDL levels.
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epinephrine despite administration of naloxone may be
explained in two ways, respectively:
1.

Short-term stress may not have produced enough
epinephrine for a long enough period of time to
cause an effect.

The naloxone further decreased

the amount of epinephrine that would normally have
been present under a naturally occurring stress
situation.
2.

The large amount of exogenous epinephrine produced
an increase in both cholesterol and LDL levels
without the benefit of B-endorphin induced stimulation of sympathetic outflow of catecholamines.
The reason for a smaller increase is that Bendorphins were not involved in the stress response.

The evidence seems to point to a mechanism involving
the action of epinephrine and B-endorphin in which both
substances contribute to the overall increase in serum
cholesterol and LDL.

Onset of stress triggers the release

of epinephrine by stimulating the hypothalamus to secrete
certain releasing factors which ac t on the adrenal medulla.
B-endorphins come into play as a result of stimulation of
various brain sites and increase existing plasma concentrations of epinephrine by also acting on the adrenal medulla.
Since B-endorphins are not easily degraded (Emrich and
Millan, 1982),

th~y

remain in the plasma and continue their

stimulatory action on the adrenal gland. _ For this reason,
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epinephrine may be present in the bloodstream for even
longer periods following a stress response than one would
expect without the effect of endorphins.

Emotional stress,

which is considered a longer lasting type of stress than
physical stress, under most conditions, can be instrumental
in increasing cholesterol levels because of its effect on
continued secretion of B-endorphins.

Physical stress, on

the other hand, unless continued over long periods, may have
only a temporary effect on B-endorphin secretion, and,
therefore, would have a somewhat lesser effect on that
particular pathway of catecholamine release.

This would

explain why rats subjected to both physical and emotional
stress (group C) had the greatest overall increase in both
total cholesterol and LDL levels.

When both pathways are

being used, for example, the additive effects would be
significant.

Epinephrine would have been released during

stress, as well as between stresses because B-endorphin
was present to insure continued epinephrine release.

During

emotional stress, this mechanism could be the method which
keeps plasma epinephrine concentrations at high levels.
Effect of Stress on
Cholesterol and LDL Levels
in Adrenalectomized Rats
Given ACTH Injections
Adlersberg and Schaefer (1950) observed hypercholesteremia of serum total cholesterol that exceeded 280 mg/dl
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when either ACTH or cortisone wa s administered to human
patients.

As illustrated in Fig. 25, ACTH is released from

the anterior pituitary gland and stimulates the adrenal
cortex to release cortisol which has various effects
including gluconeogenesis.

The abnormal cholesterol eleva-

tions in the above case may have been due to receptor interference as mentioned previously or by another mechanism
involving the increase in circulating amino acid concentration or the release of fatty acids from adipose tissue - two
important consequences of ACTH release.
During the course of the study by Adlersberg and
Schaefer (1950), it was found that fluctuations in cholesterol levels were, in general, related to changes in dosages
of ACTH or cortisone, i.e., an increase in the dosage was
often accompanied with the increase in serum cholesterol
values.

The change in cholesterol averaged +20% in the

cortisone-treated group

and +33 % in the ACTH-treated group.

These results are important in that ACTH and cortisone are
linked to stress, and since the onset of stress produces an
increase in cholesterol and LDL.

From this study, it is

reasonable to conclude that stress is a principle cause of
atherosclerosis through cholesterol synthesis.
In the present study, adrenalectomized rats that were
stressed were not expected to have any increase in either
cholesterol or LDL levels since epinephrine and corticosterone were unavailable from the adrenal medulla and adrenal
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cortex, respectively.

This was not the case, however, in

that the adrenalectomized rats had cholesterol and LDL
levels as high as the control sham-operated rats which were
also stressed.

Both groups had levels which were above the

normal range for rats of that age and weight.

At first, it

appears that a mechanism other than any of the ones already
presented may be operating in this case such as a direct
B-endorphin pathway not associated with catecholamine
release.

B-endorphin is a viable possiblity since the

present research has established it as a contributing factor
in hypercholesteremia and LDL increases.

Since epinephrine

has been strongly implicated in the increase of cholesterol
and LDL as well, some other possibilities may be equally as
convincing.

Some of the possibilities that may explain a

cholesterol increase in adrenalectomized rats are as follows:
1.

In the absence of epinephrine, B-endorphin release
became the only stimulatory agent and somehow
caused a rise in cholestero l and LDL levels without
the involvement of epinephrine.

2.

Since corticosterone was given to the adrenalectomized rats during the 10-day recovery period,
corticosterone may have contributed to cholesterol
and LDL increase via receptor interference caused
by gluconeogenesis or by another mechanism yet
unknown.
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The fact th a t the adrenalectomized rats receiving
corticosterone injections had higher levels of cholesterol
and LDL levels following stress than the control group
indicates that corticosterone may play a leading role in
stress-induced cholesterol and LDL changes when epinephrine
is not present.

The combination of injected ACTH and

physical stress may have caused a more pronounced response
and thus more cholesterol and LDL synthesis occurred.
If we examine all the results of the present study, a
more complete scheme can be hypothesized in which various
pathways are involved in altered cholesterol and lipoprotein levels (Fig. 2b).

This kind of scheme is probably

more reaslistic than one in which a single var iable or
pathway is operating.

During the course of a stressful

episode, a shift may result from one pathway to another with
one of the pathways being dominant at any given time
depending on the particular individual or the circumstance.
Individuals having certain psychological characteristics,
which make them more prone to coronary heart disease, could
have more than one dominant pathway and consequently would
increase their risk over the long term.

Coupled with diet,

heredity and lifestyle, this mechanism, if activated over
a long period of time, would certainly hasten the process
of atherosclerosis and would explain the propensity of some
individuals to contract this disease

ear~y

in life.
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Since Selye propos ed his Ge neral Adaptation Syndrome
nearly 50 years ago, researcher s have been trying to
discover the nature of the pathogenic mechanism leading to
cardiovascular disease.

This study has established that

stress and various stress hormones are involved in the
increased plasma concentrations of cholesterol and LDL, and
that B-endorphin seems to be operating as well in intensifying the reactions involved during a stress situation.
The evidence for a multiple pathway rather than a single
one is strong, but this does not preclude the possibility of
a dominant pathway which operates during the greater portion
of an individual's life and is the main source of excess
cholesterol and LDL.

Until the actual mechanism is

identified, research efforts must be intensified and focused
on the possibility of the existence of more than one
pathway.

Hopefully, this study will increase our under-

standing of the atherosclerotic mechanism and ultimately
contribute to the elimination of this disease within the
next decade.
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SUMMARY AND CONCLUSIONS
During the course of this investigation, an interesting
pattern had emerged in which the onset of st·r ess or the
injection of stress hormones (epinephrine and corticosterone)
increased serum cholesterol and LDL levels.

Furthermore, it

was observed that the stimulatory action of B-endorphin was
diminished by injecting rats with naloxone.

Both laboratory

animals and human subjects had similar reactions to stressful
situations , but it now appears that emotional stress had a
more positive effect in altering cholesterol and lipoprotein
levels than did physical stress alone.
1.

In summary:

Daily stress over a period of 2 month s continually
increased both serum total cholesterol and LDL
levels in rats while not affecting HDL or triglyceride levels.

The group that was subjected to

both physical and emotional stress had the highest
values of cholesterol and LDL.

Students undergoing

the stress of exams or dissertation defense had
total cho l esterol, LDL, and LDL/HDL levels higher
than they did during periods of non-stress.
2.

Rats that were injected daily with epinephrine in
oil had much higher cholesterol and LDL l evels but
similar HDL levels than did rats injected with
either norepinephrine or oil alone.

When the

65
treatments were reversed, the effects were also
reversed accordingly.
3.

Injection with naloxone (B-endorphin blocker) or
dichloroisoproterenol (B-adrenergic blocker) caused
an inhibition of plasma cholesterol and LDL concentrations.

The group injected with naloxone had

a much greater inhibition than the group injected
with dichloroisoproterenol which was still
significant compared with controls.
4.

Injection with naloxone plus epinephrine produced
an increase in cholesterol and LDL levels although
not as great as when epinephrine alone was injected.

5.

Adrenalectomized rats (given supplementary
injections of corticosterone) had cholesterol and
LDL levels as high as sham-operated rats when both
groups were stressed following a 10-day recovery
period.

This study has established that stress is a principle
factor in altering cholesterol and LDL synthesis either
through a direct pathway or an indirect pathway involving
the action of B-endorphin.

Since epinephrine is released

during periods of stress, and B-endorphin enhances adrenal
medullary sec retion of epinephrine, a dual pathway may be
involved in which the plasma concentration of epinephrine
is increased.

Moreover, because B-endorphins are not easily

degraded, they would remain in the circulatory system longer
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and continue their stimulatory action on the adrenal medulla
even after the originally released epinephrine has been
eliminated.

In this manner, an individual undergoing stress

over a long period of time would be subject to cholesterol
and LDL increases due to being subjected to epinephrine for
a longer period of time.
This study established that stressed rats, which were
adrenalectomized and given supplementary injections of
corticosterone, had increased levels of cholesterol and LDL
as well.

The data suggest that there was either a shift in

the pathway with B-endorphin affecting cholesterol levels
independently, or that corticosterone somehow caused an
increase in cholesterol and LDL through a separate mechanism.
In either case, there seems to be a multiple pathway rather
than a single one that increases or intensifies cholesterol
synthesis during a stress response.
Although we now know that stress and stress hormones
affect cholesterol levels, we still do not know by what
mechanism they mediate this action.

propose that the

mode of action could be receptor interference in which
cellular uptake of LDL is inhibited
epinephrine.

The

du~

to the presence of

interference may be the result of changes

in membrane permeability caused by cAMP, direct interference
caused by the epinephrine molecule itself, or indirect
interference due to the glucagon-like effect of epinephrine
in which a large volume of glucose is produced and causes
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the cell to take up the glucose instead of the LDL molecules.
A more detailed examination is needed in order to determine
whether or not the LDL receptor is prone to interference
activity or if the stress response produces so much additional endogenous LDL that cellular uptake is unable to keep
up with the amount produced.
Without question, the stress response may be acting not
only to insure the short-term survivability of an organism
under severe conditions, but in the long-term may also be
initiating a panhogenic response leading to atherosclerosis.
Certainly other factors, such as diet and heredity, would
contribute to the general susceptibility of an individual
to this disease, but stress could be the link in discovering
the main pathways and mechanisms involved.

Thus far, the

search for a cure has been illusive simply because the
pathway through which the atherosclerotic mechanism operates
has not been identified.

Perhaps now is the time to turn

our attention to behavior and psychological well-being in
order to find an answer.

Further investigations into the

role of stress in altering cholesterol leve ls may very well
carry us closer to that answer and bring to an end another
chapter in man's long history of disease.
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.l>.ppendix B

QUESTIONAIRE
Subject Name. ________________________
Address ______________________________
Tel. #______________ Ext.
Age _____ Ht.

Wt. _______

1. What type of exercise program are you currently on? (Include the number of times you actually exercise) • _________
2. Do you smoke? _______ How much? ________
3. Do you take medication for any reason? ______________________
4. Do you consume alchohol? ________ How much? ___________________
5. Do you have any illnesses at present? _______________________
6. Will you be changing your lifestyle or exercise program
between now and your next blood test? _______________________
7. Other than your comprehensives or defense, will you be
subject to any un us ua 1 stress? ________________________________
8. Does anyone in your family have:
Heart Disease________
High Blood Pressure._________
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Appendix C

Animal
Baboon
Calf
Dog

Plasma Cholesterol(mg/dl)
116

80
123

Nonkey
Rhesus

140

Squirrel

200

Pig

90

Rabbit

20

Rat

40

-Average cholesterol values for some select laboratory
animals. Adapted from Sabine , Cholesterol. 1977.
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Appendix D

Avg. Cholesterol
(Males)

Age (years)

Avg. Cholesterol
(Females)

0-4
5-9

163±1

10-14

160±1

15-19

158±1

20-24
25-29
30-34
35-39
40-44

206±1

45-49

212±1

204±1

50-54

213±1

218±1

55-59

214±1

226±1

60-64

213±1

65-69

213±1

70+

207±1

-Average cholesterol values for males and females in the
United States.

Adapted from The Lipid Research Clinics

Population Studies Data Book, U.S. Dept. of Health and
Human Services, 1980.
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Appendix D, continued

Age (years)

Avg. LDL
(Males)

Avg. LDL
(Females)

5-9

91±3

100:!:2

10-14

93:!:4

97±3

15-19

94±3

94±4

20-24

105±4

103±4

25-29

ll5±4

ll4±4

30-34

124±5

114:!:5

35-39

132:!:5

ns±s

4 0-44

137±4

123:!:6

45-49

145:1:5

129±4

50-54

146±4

138±6

55-59

149±6

147±s

60-64

152:!:6

154±6

65-69

1so±s

157±7

70+

142±4

148±4

-Average LDL values for males and females in the United
States.

Adapted from the Lipid Research Clinics Population

Studies Data Book, U.S. Dept. of Health and Human Services,

1980.
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